Misuse of prescription stimulants among college students: A review of the literature and implications for morphological and cognitive effects on brain functioning

Experimental and Clinical Psychopharmacology

Volumn 21, Issue 5, 2013, Pages 385-407

  Weyandt, Lisa L ^a   Marraccini, Marisa E ^a   Gudmundsdottir, Bergljot Gyda ^a   Zavras, Brynheld Martinez ^a   Turcotte, Kyle D ^a   Munro, Bailey A ^a   Amoroso, Alex J ^a  

^a UNIVERSITY OF RHODE ISLAND   (United States)

Author keywords

ADHD; Brain functioning; Morphological changes; Prescription stimulant misuse

Indexed keywords

ANIMALS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BRAIN; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITION; HUMANS; NORTH AMERICA; PRESCRIPTION DRUG MISUSE; PREVALENCE; SEX CHARACTERISTICS; STUDENTS; UNIVERSITIES;

EID: 84887543250     PISSN: 10641297     EISSN: 19362293     Source Type: Journal    
DOI: 10.1037/a0034013     Document Type: Article

References (124)

1. Adler, L. A., Spencer, T., McGough, J. J., Jiang, H., & Muniz, R. (2009). Long-term effectiveness and safety of dexmethylphenidate extendedrelease capsules in adult ADHD. Journal of Attention Disorders, 12, 449-459. doi:10.1177/1087054708320397
2. Allman, A. A., Benkelfat, C., Durand, F., Sibon, I., Dagher, A., Leyton, M.,. O'Driscoll, G. A. (2010). Effect of D-amphetamine on inhibition and motor planning as a function of baseline performance. Psychopharmacology, 211, 423-433. doi:10.1007/s00213-010-1912-x
3. Allman, A. A., Ettinger, U., Joober, R., & O'Driscoll, G. A. (2012). Effects of methylphenidate on basic and higher-order oculomotor functions. Journal of Psychopharmacology, 26, 1471-1479. doi:10.1177/0269881112446531
4. American Psychiatric Association. (2000). Diagnostic and statistical manual of mental disorders (4th ed., text rev.). Washington, DC: Author.
5. Arria, A. M., Caldeira, K. M., Vincent, K. B., O'Grady, K. E., & Wish, E. D. (2008). Perceived harmfulness predicts nonmedical use of prescription drugs among college students: Interactions with sensationseeking. Prevention Science: The Official Journal of the Society for Prevention Research, 9, 191-201. doi:10.1007/s11121-008-0095-8
6. Arria, A. M., Wilcox, H. C., Caldeira, K. M., Vincent, K. B., Garnier-Dykstra, L. M., & O'Grady, K. E. (2013). Dispelling the myth of "smart drugs": cannabis and alcohol use problems predict nonmedical use of prescription stimulants for studying. Addictive Behaviors, 38, 1643-1650. doi:10.1016/j.addbeh.2012.10.002
7. Arria, A. M., & Wish, E. D. (2006). Nonmedical use of prescription stimulants among student. Pediatric Annals, 35, 565. Retrieved from http://www.healio.com/pediatrics/journals/pedann
8. Babcock, Q., & Byrne, T. (2000). Student perceptions of methylphenidate abuse at a public liberal arts college. Journal of American College Health, 49, 143-145. doi:10.1080/07448480009596296
9. Barkley, R. A., Murphy, K. R., & Fischer, M. (2008). ADHD in adults:What the science says. New York, NY: Guilford Press.
10. Barnett, R., Maruff, P., & Vance, A. (2005). An investigation of visuospatial memory impairment in children with attention deficit hyperactivity disorder (ADHD), combined type. Psychological Medicine, 35, 1433-1443. doi:10.1017/S0033291705005234
11. Barrett, S., Darredeau, C., Bordy, L. E., & Pihl, R. O. (2005). Characteristics of methylphenidate misuse in a university student sample. The Canadian Journal of Psychiatry, 50, 457-461. Retrieved from http://publications.cpa-apc.org/browse/sections/0
12. Baverstock, A. C., & Finlay, F. (2003). Who manages the care of students with attention deficit hyperactivity disorder (ADHD) in higher education? Child: Care, Health and Development, 29, 163-166. doi:10.1046/j.1365-2214.2003.00327.x
13. Berridge, C. W., Devilbiss, D. M., Andrzejewski, M. E., Arnsten, A. F. T., Kelley, A. E., Schmeichel, B.,. Spencer, R. C. (2006). Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biological Psychiatry, 60, 1111-1120. doi:10.1016/j.biopsych.2006.04.022
14. Biederman, J., Mick, E., & Faraone, S. V. (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: Impact of remission definition and symptom type. American Journal of Psychiatry, 157, 816-818. doi:10.1176/appi.ajp.157.5.816
15. Biederman, J., Mick, E., Fried, R., Wilner, N., Spencer, T. J., & Faraone, S. V. (2011). Are stimulants effective in the treatment of executive function deficits? Results from a randomized double blind study of OROS-methylphenidate in adults with ADHD. European Neuropsychopharmacology, 21, 508-515. doi:10.1016/j.euroneuro.2010.11.005
16. Biederman, J., Seidman, L. J., Petty, C. R., Fried, R., Doyle, A. E., Cohen, D. R.,. Faraone, S. V. (2008). Effects of stimulant medication on neuropsychological functioning in young adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry, 69, 1150-1156. doi:10.4088/JCP.v69n0715
17. Bledsoe, J., Semrud-Clikeman, M., & Pliszka, S. R. (2009). A magnetic resonance imaging study of the cerebellar vermis in chronically treated and treatment-naïve children with attention deficit/hyperactivity disorder combined type. Biological Psychiatry, 65, 620-624. doi:10.1016/j.biopsych.2008.11.030
18. Boikess, S. R., & Marshall, J. F. (2008). A sensitizing d-amphetamine regimen induces long-lasting spinophilin protein upregulation in the rat striatum and limbic forebrain. European Journal of Neuroscience, 28, 2099-2107. doi:10.1111/j.1460-9568.2008.06481.x
19. Boonstra, A. M., Kooij, J. J., Oosterlaan, J., Sergeant, J. A., & Buitelaar, J. K. (2005). Does methylphenidate improve inhibition and other cognitive abilities in adults with childhood-onset ADHD? Journal of Clinical and Experimental Neuropsychology, 27, 278-298. doi:10.1080/13803390490515757
20. Brackenridge, R., McKenzie, K., Murray, G. C., & Quigley, A. (2011). An examination of the effects of stimulant medication on response inhibition:A comparison between children with and without attention deficit hyperactivity disorder. Research in Developmental Disabilities, 32, 2797-2804. doi:10.1016/j.ridd.2011.05.027
21. Broyd, S. J., Johnstone, S. J., Barry, R. J., Clarke, A. R., McCarthy, R., Selikowitz, M., & Lawrence, C. A. (2005). The effect of methylphenidate on response inhibition and the event-related potential of children with attention deficit/hyperactivity disorder. International Journal of Psychophysiology, 58, 47-58. doi:10.1016/j.ijpsycho.2005.03.008
22. Bush, G., Spencer, T. J., Holmes, J., Shin, L. M., Valera, E. M., Seidman, L. J.,. Biederman, J. (2008). Functional magnetic resonance imaging of methylphenidate and placebo in attention-deficit/hyperactivity disorder during the multi-source interference task. Archives of General Psychiatry, 65, 102-114. doi:10.1001/archgenpsychiatry.2007.16
23. Claussen, C., & Dafny, N. (2012). Acute and chronic methylphenidate modulates the neuronal activity of the caudate nucleus recorded from freely behaving rats. Brain Research Bulletin, 87, 387-396. doi:10.1016/j.brainresbull.2011.10.008
24. Clegg-Kraynok, M. M., McBean, A. L., & Montgomery-Downs, H. E. (2011). Sleep quality and characteristics of college students who use prescription psychostimulants nonmedically. Sleep Medicine, 12, 598-602. doi:10.1016/j.sleep.2011.01.012
25. Coghill, D. R., Rhodes, S. M., & Matthews, K. (2007). The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biological Psychiatry, 62, 954-962. doi:10.1016/j.biopsych.2006.12.030
26. Cohen, J. (1992). A power primer. Psychological Bulletin, 112, 155-159. doi:10.1037/0033-2909
27. Costa, A., Riedel, M., Pogarell, O., Menzel-Zelnitschek, F., Schwarz, M., Reiser, M.,. Ettinger, U. (2013). Methylphenidate effects on neural activity during response inhibition in healthy humans. Cerebral Cortex, 23, 1179-1189. doi:10.1093/cercor/bhs107
28. DeSantis, A. D., Webb, E. M., & Noar, S. M. (2008). Illicit use of prescription ADHD medications on a college campus: A multimethodological approach. Journal of American College Health, 57, 315-324. doi:10.3200/JACH.57.3.315-324
29. Devilbiss, D. M., & Berridge, C. W. (2006). Low-dose methylphenidate actions on tonic and phasic locus coeruleus discharge. Journal of Pharmacology and Experimental Therapeutics, 319, 1327-1335. doi:10.1124/jpet.106.110015
30. DeVito, E. E., Blackwell, A. D., Kent, L., Ersche, K. D., Clark, L., Salmond, C. H.,. Sahakian, B. J. (2008). The effects of methylphenidate on decision making in attention-deficit/hyperactivity disorder. Biological Psychiatry, 64, 636-639. doi:10.1016/j.biopsych.2008.04.017
31. Dodge, T., Williams, K. J., Marzell, M., & Turrisi, R. (2012). Judging cheaters: Is substance misuse viewed similarly in the athletic and academic domains? Psychology of Addictive Behaviors, 26, 678-682. doi:10.1037/a0027872
32. DuPaul, G. J., Schaughency, E. A., Weyandt, L. L., Tripp, G., Kiesner, J., Ota, K., & Stanish, H. (2001). Self-report of ADHD symptoms in university students: Cross-gender and cross-national prevalence. Journal of Learning Disabilities, 34, 370-379. doi:10.1177/002221940103400412
33. DuPaul, G. J., & Weyandt, L. L. (2009). College students with ADHD:Current status and future directions. Journal of Attention Disorders, 13, 234-250. doi:10.1177/1087054709340650
34. DuPaul, G. J., Weyandt, L. L., Rossi, J. S., Vilardo, B. A., O'Dell, S. M., Carson, K.,. Swentosky, A. (2012). Double-blind, placebo-controlled, crossover study of the efficacy and safety of lisdexamfetamine dimesylate in college students with ADHD. Journal of Attention Disorders, 16, 202-220. doi:10.1177/1087054711427299
35. Dupont, R. L., Coleman, J. J., Bucher, R. H., & Wilford, B. B. (2008). Characteristics and motives of college students who engage in nonmedical use of methylphenidate. American Journal on Addictions, 17, 167-171. doi:10.1080/10550490802019642
36. Dussault, C. L., & Weyandt, L. L. (2013). An examination of prescription stimulant misuse and psychological variables among sorority and fraternity college populations. Journal of Attention Disorders, 17, 87-97. doi:10.1177/1087054711428740
37. Franke, A. G., Bonertz, C., Christmann, M., Huss, M., Fellgiebel, A., Hildt, E., & Lieb, K. (2011). Non-medical use of prescription stimulants and illicit use of stimulants for cognitive enhancement in pupils and students in Germany. Pharmacopsychiatry, 44, 60-66. doi:10.1055/s-0030-1268417
38. Garnier-Dykstra, L. M., Caldeira, K. M., Vincent, K. B., O'Grady, K. E., & Arria, A. M. (2012). Nonmedical use of prescription stimulants during college: Four-year trends in exposure opportunity, use, motives, and sources. Journal of American College Health, 60, 226-234. doi:10.1080/07448481.2011.589876
39. Gimpel, G. A., Collett, B. R., Veeder, M. A., Gifford, J. A., Sneddon, P., Bushman, B., Hughes, K., & Odell, J. D. (2005). Effects of stimulant medication on cognitive performance of children with ADHD. Clinical Pediatrics, 44, 405-411.
40. Goitia, B., Raineri, M., González, L. E., Rozas, J. L., Garcia-Rill, E., Bisagno, V., & Urbano, F. J. (2013). Differential effects of methylphenidate and cocaine on GABA transmission in sensory thalamic nuclei. Journal of Neurochemistry, 124, 602-612. doi:10.1111/jnc.12113
41. Gomes, K. M., Inacio, C. G., Valvassoria, S. S., Reusa, G. Z., Boecka, C. R., Dal-Pizzol, F., & Quevedoa, J. (2009). Superoxide production after acute and chronic treatment with methylphenidate in young and adult rats. Neuroscience Letters, 465, 95-98. doi:10.1016/j.neulet.2009.08.060
42. Guthrie, B. (2002). The college experience. In K. Nadeau & P. Quinn (Eds.), Understanding women with ADHD (pp. 288-312). Silver Spring, MD: Advantage.
43. Hall, K. M., Irwin, M. M., Bowman, K. A., Frankenberger, W., & Jewett, D. C. (2005). Illicit use of prescribed stimulant medication among college students. Journal of American College Health, 53, 167-174. doi:10.3200/JACH.53.4.167-174
44. Hanson, C. L., Burton, S. H., Giraud-Carrier, C., West, J. H., Barnes, M. D., & Hansen, B. (2013). Tweaking and tweeting: Exploring Twitter for nonmedical use of a psychostimulant drug (adderall) among college students. Journal of Medical Internet Research, 15, e62. doi:10.2196/jmir.2503
45. Heiligenstein, E., Conyers, L. M., Berns, A. R., & Smith, M. A. (1998). Preliminary normative data on DSM-IV attention deficit disorder in college students. Journal of American College Health, 46, 185-188. doi:10.1080/07448489809595609
46. Hellwig-Brida, S., Daseking, M., Keller, F., Petermann, F., & Goldbeck, L. (2011). Effects of methylphenidate on intelligence and attention components in boys with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 21, 245-253. doi:http://0-dx.doi.org.helin.uri.edu/10.1089/cap.2010.0041
47. Hoekzema, E., Carmona, S., Ramos-Quiroga, J. A., Canals, C., Moreno, A., Fernández, V. R.,. Vilarroya, O. (2012). Stimulant drugs trigger transient volumetric changes in the human ventral striatum. Brain Structure and Function, 1-12. doi:10.1007/s00429-012-0481-7
48. Janusis, G. M., & Weyandt, L. L. (2010). An exploratory study of substance use and misuse among college students with and without ADHD and other disabilities. Journal of Attention Disorders, 14, 205-215. doi:10.1177/1087054710367600
49. Judson, R., & Langdon, S. W. (2009). Illicit use of prescription stimulants among college students: Prescription status, motives, theory of planned behaviour, knowledge and self-diagnostic tendencies. Psychology, Health & Medicine, 14, 97-104. doi:10.1080/13548500802126723
50. Jung, C., Choi, S., Jeong, S., Song, C., Seo, W., Chung, U., & Lee, J. (2007). Multicenter, open-label study to evaluate the effects of methylphenidate-oros (Concerta) on cognitive functions in children with attention deficit hyperactivity disorder. Clinical Psychopharmacology and Neuroscience, 5, 31-37.
51. Katsurra, Y., & McGrogan, K. (2013). The abuse of stimulant drugs within the medical education setting. Royal College of Surgeons in Ireland Student Medical Journal, 6, 74-78. Retrieved from http://www.rcsismj.com/
52. Kaye, S., & Darke, S. (2012). The diversion and misuse of pharmaceutical stimulants: What do we know and why should we care? Addiction, 107, 467-477. doi:10.1111/j.1360-0443.2011.03720.x
53. Klimkeit, E. I., Mattingley, J. B., Sheppard, D. M., Lee, P., & Bradshaw, J. L. (2005). Motor preparation, motor execution, attention, and executive functions in attention deficit/hyperactivity disorder (ADHD). Child Neuropsychology, 11, 153-173. doi:10.1080/092970490911298
54. Kroutil, L. A., Van Brunt, D. L., Herman-Stahl, M. A., Heller, D. C., Bray, R. M., & Penne, M. A. (2006). Nonmedical use of prescription stimulants in the United States. Drug Alcohol Dependence, 84, 135-143. doi:10.1016/j.drugalcdep.2005.12.011
55. Kubas, H. A., Backenson, E. M., Wilcox, G., Piercy, J. C., & Hale, J. B. (2012). The effects of methylphenidate on cognitive function in children with attention-deficit/hyperactivity disorder. Postgraduate Medicine, 124, 33-48.
56. Langleben, D. D., Monterosso, J., Elman, I., Ash, B., Krikorian, G., & Austin, G. (2006). Effect of methylphenidate on Stroop Color-Word task performance in children with attention deficit hyperactivity disorder. Psychiatry Research, 141, 315-320.
57. Lee, J. S., Kim, B. N., Kang, E., Lee, D. S., Kim, Y. K., Chung, J. K.,. Churl, S. C. (2005). Regional cerebral blood flow in children with attention deficit hyperactivity disorder: Comparison before and after methylphenidate treatment. Human Brain Mapping, 24, 157-164. doi:10.1002/hbm.20067
58. Lee, T. H., Lee, C. H., Kim, I. H., Yan, B. C., Park, J. H.,. Kim, S. K. (2008). Effects of ADHD therapeutic agents, methylphenidate and atomoxetine, on hippocampal neurogenesis in the adolescent mouse dentate gyrus. Neuroscience Letters, 524, 84-88. doi:10.1016/j.neulet.2012.07.029
59. Looby, A., & Earleywine, M. (2011). Expectation to receive methylphenidate enhances subjective arousal but not cognitive performance. Experimental and Clinical Psychopharmacology, 19, 433. doi:10.1037/a0025252
60. Lookatch, S. J., Dunne, E. M., & Katz, E. C. (2012). Predictors of nonmedical use of prescription stimulants. Journal of Psychoactive Drugs, 44, 86-91. doi:10.1080/02791072.2012.662083
61. Lord, S., Downs, G., Furtaw, P., Chaudhuri, A., Silverstein, A., Gammaitoni, A., & Budman, S. (2009). Nonmedical use of prescription opioids and stimulants among student pharmacists. Journal of the American Pharmacists Association, 49, 519-528. doi:10.1331/JAPhA.2009.08027
62. Low, K. G., & Gendaszek, A. E. (2002). Illicit use of psychostimulants among college students: A preliminary study. Psychology, Health & Medicine, 7, 283-287. doi:10.1080/13548500220139386
63. Martins, M. R., Reinke, A., Petronilho, F. C., Gomes, K. M., Dal-Pizzol, F., & Quevedoa, J. (2006). Methylphenidate treatment induces oxidative stress in young rat brain. Brain Research, 1078, 189-197. doi:10.1016/j.brainres.2006.01.004
64. McCabe, S. E. (2008). Screening for drug abuse among medical and nonmedical users of prescription drugs in a probability sample of college students. Archives of Pediatrics & Adolescent Medicine, 162, 225-231. doi:10.1001/archpediatrics.2007.41
65. McCabe, S. E., & Boyd, C. J. (2005). Sources of prescription drugs for illicit use. Addictive Behaviors, 30, 1342-1350. doi:10.1016/j.addbeh.2005.01.012
66. McCabe, S. E., Boyd, C. J., & Teter, C. J. (2009). Subtypes of nonmedical prescription drug misuse. Drug and Alcohol Dependence, 102, 63-70. doi:10.1016/j.drugalcdep.2009.01.007
67. McCabe, S. E., Knight, J. R., Teter, C. J., & Wechsler, H. (2005). Non-medical use of prescription stimulants among US college students:Prevalence and correlates from a national survey. Society for the Study of Addiction, 99, 96-106. doi:10.1111/j.1360-0443.2005.00944.x
68. McCabe, S. E., & Teter, C. J. (2007). Drug use related problems among nonmedical users of prescription stimulants: A web-based survey of college students from a Midwestern university. Drug and Alcohol Dependence, 91, 69-76. doi:10.1016/j.drugalcdep.2007.05.010
69. McCabe, S. E., Teter, C. J., & Boyd, C. J. (2006a). Medical use, illicit use, and diversion of abusable prescription drugs. Journal of American College Health, 54, 269-278. doi:10.3200/JACH.54.5.269-278
70. McCabe, S. E., Teter, C. J., & Boyd, C. J. (2006b). Medical use, illicit use and diversion of prescription stimulant medication. Journal of Psychoactive Drugs, 38, 43-56. doi:10.1080/02791072.2006.10399827
71. McNiel, A. D., Muzzin, K. B., DeWald, J. P., McCann, A. L., Schneiderman, E. D., Scofield, J., & Campbell, P. R. (2011). The nonmedical use of prescription stimulants among dental and dental hygiene students. Journal of Dental Education, 75, 365-376. Retrieved from http://www.jdentaled.org/
72. Mikami, A. Y., Cox, D. J., Davis, M. T., Wilson, H. K., Merkel, R. L., & Burket, R. (2009). Sex differences in effectiveness of extended-release stimulant medication among adolescents with attention-deficit/hyperactivity disorder. Journal of Clinical Psychology in Medical Settings, 16, 233-242. doi:10.1007/s10880-009-9165-8
73. Murray, D. W., Childress, A., Giblin, J., Williamson, D., Armstrong, R., & Starr, H. L. (2011). Effects of OROS methylphenidate on academic, behavioral, and cognitive tasks in children 9 to 12 years of age with attention-deficit/hyperactivity disorder. Clinical Pediatrics, 50, 308-320.
74. Nakao, T., Radua, J., Rubia, K., & Mataix-Cols, D. (2011). Gray matter volume abnormalities in ADHD: Voxel-based meta-analysis exploring the effects of age and stimulant medication. American Journal of Psychiatry, 168, 1154-1163. doi:10.1176/appi.ajp.2011.11020281
75. Nandam, L. S., Hester, R., Wagner, J., Cummins, T. D., Garner, K., Dean, A. J.,. Bellgrove, M. A. (2011). Methylphenidate but not atomoxetine or citalopram modulates inhibitory control and response time variability. Biological Psychiatry, 69, 902-904. doi:10.1016/j.biopsych.2010.11.014
76. O'Driscoll, G. A., Depatie, L., Holahan, A. L., Savion-Lemieux, T., Barr, R. G., Jolicoeur, C., & Douglas, V. I. (2005). Executive functions and methylphenidate response in subtypes of attention-deficit/hyperactivity disorder. Biological Psychiatry, 57, 1452-1460.
77. Okoli, C., & Schabram, K. (2010). A guide to conducting a systematic literature review of information systems research. Sprouts: Working Papers on Information Systems, 10. http://sprouts.aisnet.org/10-26
78. Pasini, A., Sinibaldi, L., Paloscia, C., Douzgou, S., Pitzianti, M. B., Romeo, E.,. Pizzuti, A. (2013). Neurocognitive effects of methylphenidate on ADHD children with different DAT genotypes: A longitudinal open label trial. European Journal of Paediatric Neurology. doi:10.1016/j.ejpn.2013.02.002
79. Peterkin, A. L., Crone, C. C., Sheridan, M. J., & Wise, T. N. (2010). Cognitive performance enhancement: Misuse or self-treatment? Journal of Attention Disorders, 15, 263-268. doi:10.1177/1087054710365980
80. Prieto-Gomez, B., Benitez, M. T., Vazquez-Alvarez, A. M., Yang, P. B., Vazquez, C. R., & Dafny, N. (2004). Dopaminergic ventral tegmental neurons modulated by methylphenidate. Life Sciences, 74, 1581-1592. doi:10.1016/j.lfs.2003.07.047
81. Rabiner, D. L., Anastopoulos, A. D., Costello, E. J., Hoyle, R. H., McCabe, S. E., & Swartzwelder, H. S. (2009). Motives and perceived consequences of nonmedical ADHD medication use by college students: Are students treating themselves for attention problems? Journal of Attention Disorders, 13, 259-270. doi:10.1177/1087054708320399
82. Rapoport, J. L., Buchsbaum, M. S., Zahn, T. P., Weingartner, H., Ludlow, C., & Mikkelsen, E. J. (1978). Dextroamphetamine: Cognitive and behavioral effects in normal prepubertal boys. Science, 199, 560-563. doi:10.1126/science.341313
83. Rhodes, S. M., Coghill, D. R., & Matthews, K. (2006). Acute neuropsychological effects of methylphenidate in stimulant drug-naive boys with ADHD II - broader executive and non-executive domains. Journal of Child Psychology and Psychiatry, 47, 1184-1194. doi:10.1111/j.1469-7610.2006.01633.x
84. Rozenbroek, K., & Rothstein, W. G. (2011). Medical and nonmedical users of prescription drugs among college students. Journal of American College Health, 59, 358-363. doi:10.1080/07448481.2010.512044
85. Scherer, E. B. S., Matte, C., Ferreira, A. G. K., Gomes, K. M., Comim, C., Mattos, C.,. Wyse, A. T. S. (2009). Methylphenidate treatment increases Na+, K+-ATPase activity in the cerebrum of young and adult rats. Journal of Neural Transmission, 116, 1681-1687. doi:10.1007/s00702-009-0306-x
86. Schulz, K. P., Fan, J., Bedard, A. C. V., Clerkin, S. M., Ivanov, I., Tang, C. Y.,. Newcorn, J. H. (2012). Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attentiondeficit/hyperactivity disorder. Archives of General Psychology, 69, 952-961. doi:10.1001/archgenpsychiatry.2011.2053
87. Schweitzer, J. B., Lee, D. O., Hanford, R. B., Zink, C. F., Ely, T. D., Tagamets, M. A.,. Kilts, C. D., (2004). Effect of methylphenidate on executive functioning in adults with attention-deficit/hyperactivity disorder:Normalization of behavior but not related brain activity. Biological Psychiatry, 56, 597-606. doi:10.1016/j.biopsych.2004.07.011
88. Scotter, E., & Meaux, J. (2008). Prescription stimulant misuse among college students. Journal of Pediatric Nursing, 23, 21. doi:10.1016/j.pedn.2008.01.068
89. Semrud-Clikeman, M., Pliszka, S., & Liotti, M. (2008). Executive functioning in children with attention-deficit/hyperactivity disorder: Combined type with and without a stimulant medication history. Neuropsychology, 22, 329-340. doi:10.1037/0894-4105.22.3.329
90. Shaw, P., Sharp, W., Morrison, M., Eckstrand, K., Greenstein, D., Clasen, L.,. Rapoport, J. L. (2009). Psychostimulant treatment and the developing cortex in attention-deficit/hyperactivity disorder. The American Journal of Psychiatry, 166, 58-63. doi:10.1176/appi.ajp.2008.08050781
91. Smith, M. E., & Farah, M. J. (2011). Are prescription stimulants "smart pills"? The epidemiology and cognitive neuroscience of prescription stimulant use by normal healthy individuals. Psychological Bulletin, 137, 717-741. doi:10.1037/a0023825
92. Snyder, A. M., Maruff, P., Pietrzak, R. H., Cromer, J. R., & Snyder, P. J. (2008). Effect of treatment with stimulant medication on nonverbal executive function and visuomotor speed in children with attention deficit/hyperactivity disorder (ADHD). Child Neuropsychology, 14, 211-226.
93. Sobel, L. J., Bansal, R., Maia, T. V., Sanchez, J., Mazzone, L., Durkin, K.,. Peterson, B. S. (2010). Basal ganglia surface morphology and the effects of stimulant medications in youth with attention deficit hyperactivity disorder. American Journal of Psychiatry, 167, 977-986. doi:10.1176/appi.ajp.2010.09091259
94. Spencer, T. J., Biederman, J., & Wilens, T. (1998). Pharmacotherapy of ADHD with antidepressants. In R. Barkley (Ed.), Attention-deficit hyperactivity disorder: A handbook for diagnosis and treatment (2nd ed., pp. 552-563). New York, NY: Guilford Press.
95. Sprague, R. L., & Sleator, E. K. (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274-1276. doi:10.1126/science.337493
96. Staufer, W. B., & Greydanus, D. E. (2005). Attention-deficit/hyperactivity disorder psychopharmacology for college students. The Pediatric Clinics of North America, 52, 71-84. doi:10.1016/j.pcl.2004.10.007
97. Stone, A. M., & Merlo, L. J. (2011). Attitudes of college students toward mental illness stigma and the misuse of psychiatric medications. Journal of Clinical Psychiatry, 72, 134-139. doi:10.4088/JCP.09m05254ecr
98. Stoy, M., Schlagenhauf, F., Schlochtermeier, L., Wrase, J., Knutson, B., Lehmkuhl, U.,. Ströhle, A. (2011). Reward processing in male adults with childhood ADHD -a comparison between drug-naïve and methylphenidate-treated subjects. Psychopharmacology, 215, 467-481. doi:10.1007/s00213-011-2166-y
99. Szobot, C. M., Ketzer, C., Cunha, R. D., Parente, M. A., Langleben, D. D., Acton, P. D.,. Rohde, L. A. P. (2003). The acute effect of methylphenidate on cerebral blood flow in boys with attention-deficit/hyperactivity disorder. European Journal of Nuclear Medicine, 30, 423-426. doi:10.1007/s00259-002-1082-0
100. Teter, C. J., McCabe, S. E., Boyd, C. J., & Guthrie, S. K. (2003). Illicit methylphenidate use in an undergraduate student sample: Prevalence and risk factors. Pharmacotherapy, 23, 609-617.
101. Teter, C. J., McCabe, S. E., Cranford, J. A., Boyd, C. J., & Guthrie, S. K. (2005). Prevalence and motives for illicit use of prescription stimulants in an undergraduate student sample. Journal of American College Health, 53, 253-262. doi:10.3200/JACH.53.6.253-262
102. Teter, C. J., McCabe, S. E., LaGrange, K., Cranford, J. A., & Boyd, C. J. (2006). Illicit use of specific prescription stimulants among college students: Prevalence, motives, and routes of administration. Pharmacotherapy, 26, 1501-1510. doi:10.1592/phco.26.10.1501
103. Tomasi, D., Volkow, N. D., Wang, G. J., Wang, R., Telang, F., Caparelli, E. C.,. Fowler, J. S. (2011). NeuroImage, 54, 3101-3110. doi:10.1016/j.neuroimage.2010.10.060
104. Tucha, L., Tucha, O., Sontag, T. A., Stasik, D., Laufkotter, R., & Lange, K. W. (2011). Differential effects of methylphenidate on problem solving in adults with ADHD. Journal of Attention Disorders, 15, 161-173. doi:10.1177/1087054709356391
105. Turner, D. C., Blackwell, A. D., Dowson, J. H., McLean, A., & Sahakian, B. J. (2005). Neurocognitive Effects of methylphenidate in adult attention-deficit/hyperactivity disorder. Psychopharmacology, 178, 286-295.
106. Turner, D. C., Clark, L., Dowson, J., Robbins, T. W., & Sahakian, B. J. (2004). Modafinil improves cognition and response inhibition in adult attention-deficit/hyperactivity disorder. Biological Psychiatry, 55, 1031-1040. doi:10.1016/j.biopsych.2004.02.008
107. Turner, D. C., Robbins, T. W., Clark, L., Aron, A. R., Dowson, J., & Sahakian, B. J. (2003). Cognitive enhancing effects of modafinil in healthy volunteers. Psychopharmacology, 165, 260-269. doi:10.1007/s00213-002-1250-8
108. Urban, K. R., Waterhouse, B. D., & Gao, W. J. (2012). Distinct agedependent effects of methylphenidate on developing and adult prefrontal neurons. Biological Psychiatry, 72, 880-888. doi:10.1016/j.biopsych.2012.04.018
109. Volkow, N. D., Fowler, J. S., Wang, G. J., Telang, F., Logan, J., Wong, C.,. Swanson, J. M. (2008). Methylphenidate decreased the amount of glucose needed by the brain to perform a cognitive task. PLoS ONE 3, e2017. doi:10.1371/journal.pone.0002017
110. Volkow, N. D., Wang, G. J., Tomasi, D., Kollins, S. H., Wigal, T. L., Newcorn, J. H.,. Swanson, J. M. (2012). Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder. The Journal of Neuroscience, 32, 841-849. doi:10.1523/JNEUROSCI.4461-11.2012
111. Webb, J. R., Valasek, M. A., & North, C. S. (2013). Prevalence of stimulant use in a sample of US medical students. Annals of clinical psychiatry: Official journal of the American Academy of Clinical Psychiatrists, 25, 27-32. Retrieved from http://www.aacp.com/
112. Westover, A. N., & Halm, E. A. (2012). Do prescription stimulants increase the risk of adverse cardiovascular events? A systematic review. BMC Cardiovascular Disorders, 12, 41. doi:10.1186/1471-2261-12-41
113. Weyandt, L. L. (2007). An ADHD primer (2nd ed., p. 71) Mahwah, NJ:Routledge.
114. Weyandt, L. L., Janusis, G., Wilson, K. G., Verdi, G., Paquin, G., Lopes, J.,. Dussault, C. (2009). Nonmedical prescription stimulant use among a sample of college students: Relationship with psychological variables. Journal of Attention Disorders, 13, 284-296. doi:10.1177/1087054709342212
115. Weyandt, L. L., Linterman, I., & Rice, J. A. (1995). Reported prevalence of attentional difficulties in a general sample of college students. Journal of Psychopathology and Behavioral Assessment, 17, 293-304. doi:10.1007/BF02229304
116. White, B. P., Becker-Blease, K. A., & Grace-Bishop, K. (2006). Stimulant medication use, misuse, and abuse in an undergraduate and graduate student sample. Journal of American College Health, 54, 261-268. doi:10.3200/JACH.54.5.261-268
117. Wigal, S. B., Wigal, T., Schuck, S., Brams, M., Williamson, D., Armstrong, R. B., & Starr, H. L. (2011). Academic, behavioral, and cognitive effects of OROS methylphenidate on older children with attentiondeficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 21, 121-131. doi:http://0-dx.doi.org.helin.uri.edu/10.1089/cap.2010.0047
118. Wilens, T. E., Faraone, S. V., & Biederman, J. (2004). Attention-deficit/hyperactivity disorder in adults. The Journal of American Medical Association, 292, 619-623. doi:10.1001/jama.292.5.619
119. Wilson, H. K., Cox, D. J., Merkel, R. L., Moore, M., & Coghill, D. (2006). Effect of extended release stimulant-based medications on neuropsychological functioning among adolescents with attention-deficit/hyperactivity disorder. Archives of Clinical Neuropsychology, 21, 797-807.
120. Yildiz Oc, O., Agaoglu, B., Sen Berk, F., Komsuoglu, S., Karakaya, I., & Coskun, A. (2007). Evaluation of the effect of methylphenidate by computed tomography, electroencephalography, neuropsychological tests, and clinical symptoms in children with attention-deficit/hyperactivity disorder: A prospective cohort study. Current Therapeutic Research, 68, 432-449. doi:10.1016/j.curtheres.2007.12.003
121. Zeeuws, I., Deroost, N., & Soetens, E. (2010a). Effect of an acute d-amphetamine administration on context information memory in healthy volunteers: Evidence from a source memory task. Human Psychopharmacology:Clinical and Experimental, 25, 326-334. doi:10.1002/hup.1120
122. Zeeuws, I., Deroost, N., & Soetens, E. (2010b). Verbal memory improved by D-amphetamine: Influence of the testing effect. Human Psychopharmacology:Clinical and Experimental, 25, 377-387. doi:10.1002/hup.1128
123. Zeeuws, I., & Soetens, E. (2007). Verbal memory performance improved via an acute administration of D-amphetamine. Human Psychopharmacology:Clinical and Experimental, 22, 279-287. doi:10.1002/hup.848
124. Zhang, L., Jin, X., & Zhang, Y. (2011). Effect of methylphenidate on intelligence quotient scores in Chinese children with attention-deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology, 31, 51-55. doi:10.1097/JCP.0b013e3182060f3f